Metabolic pathways and inflammatory processes are under circadian regulation. While rhythmic 22
immune cell recruitment is known to impact infection outcomes, whether the circadian clock 23 modulates immunometabolism remains unclear. We find the molecular clock Bmal1 is induced by 24 inflammatory stimulants, including Ifn-g/lipopolysaccharide (M1) and tumor conditioned medium, 25 to maintain mitochondrial metabolism under these metabolically stressed conditions in mouse Inflammation and host defense are energetically costly processes that must balance the use of host 39 resources with an efficient containment of infection or injury. This is underpinned by dynamic 40 regulation of energy metabolism in immune cells in response to extrinsic signals, including 41 cytokines, pathogen-and damage-associated molecular patterns and tumor-derived metabolites 42 (Andrejeva & Rathmell, 2017 Tannahill et al., 2013) . The depressed mitochondrial function appears to be by 48 design, as this process serves multiple purposes. It leads to the so-called 'broken TCA cycle' due 49 in part to shunting of citric acid to lipid synthesis (Andrejeva & Rathmell, 2017) . Itaconate, also 50 derived from citrate/aconitate, can modulate macrophage immune response through different 51 mechanisms (Lampropoulou et al., 2016; Mills et al., 2018) . By contrast, succinate accumulates 52 through anaplerotic reactions, notably glutaminolysis (Tannahill et al., 2013) . Succinate oxidation 53 to fumarate mediated by succinate dehydrogenase (SDH)/ETC complex II activity is a primary 54 source of mitochondrial reactive oxygen species (mROS) in inflammatory macrophages that are 55 involved in bactericidal activity (Mills et al., 2016; West et al., 2011) . Succinate/SDH is believed 56 to trigger mROS production through accumulation of reduced coenzyme Q leading to reverse 57 electron transfer to ETC complex I (Chouchani et al., 2014; Robb et al., 2018) . These findings 58 demonstrate a well-orchestrated metabolic signaling event at the expense of reduced fuel economy 59 and compromised mitochondrial function in macrophages. 60 was directly added to the cell culture without changing the medium, the induction of Bmal1 was 126 not due to serum shock (Tamaru et al., 2003) . In fact, a one-hour LPS treatment in culture medium 127 with 2% serum was sufficient to reset Bmal1 expression ( Figure 1C ), in a manner resembling 128 serum shock (requiring a much higher serum concentration). Similar results were observed in 129 mouse embryonic fibroblasts (MEFs), suggesting that the inflammatory regulation of Bmal1 was 130 not macrophage-specific (Figure 1 supplemental figure 1B) . 131
Myeloid-specific Bmal1 knockout (M-BKO, Bmal1f/f crossed to Lyz2-Cre; Bmal1f/f was 132 used as the wild-type control, WT) mice were generated to determine the role of circadian clock 133 in macrophage function. M-BKO did not affect M1 induction of canonical inflammatory 134 regulators, such as Nfkb1, Stat3, Hif1a and c-Myc ( Figure 1D 2007), we sought to determine the role of Bmal1 in macrophage bioenergetic control. In WT 146 macrophages, M1 activation caused a progressive decrease in mitochondrial content, which was 147 more pronounced in M-BKO macrophages (Figure 2A ). The reduced mitochondrial content was 148 likely due to mitophagy, as demonstrated by the increased level of the mitophagy receptor Bnip3 149 ( Figure 2B ). Measurement of ETC complex activity in isolated mitochondria indicated that M-150 BKO also caused a significant reduction in the activities of complex II and III, given an equal 151 amount of mitochondrial protein, 6 hours after M1 stimulation ( Figure 2C ). Seahorse extracellular 152 flux analysis showed that LPS injection increased the extracellular acidification rate (ECAR, 153 indicative of lactic acid secretion) and decreased the oxygen consumption rate (OCR) of WT 154 macrophages, as expected from aerobic glycolysis ( Figure 2D ). The ECAR and OCR were further 155 enhanced and suppressed, respectively, in M-BKO macrophages. Similar results were obtained in 156 thioglycollate-elicited peritoneal macrophages isolated from WT and M-BKO mice (Figure 2 To further assess the metabolic state, metabolomics analyses were employed to compare 170 cellular metabolite levels of WT and M-BKO macrophages 0, 6 and 12 hours after M1 activation 171 ( Figure 3A Figure 4B ). Hif-1a gene expression was not different between WT and M-191 BKO cells ( Figure 1D ). mROS derived from increased succinate oxidation has previously been 192 demonstrated to stabilize Hif-1a protein in inflammatory macrophages (Mills et al., 2016). 193 Metabolite analyses showed accumulation of succinate in M-BKO macrophages, suggesting that 194 elevated mROS may be the cause of the increased Hif-1a protein. In fact, levels of mROS were 195 higher in isolated mitochondria from M-BKO macrophages at 1 and 4 hours of M1 activation 196 compared to WT macrophages ( Figure 4C ). Addition of succinate increased mROS production in 197 mitochondria from both WT and M-BKO macrophages. An additional two-fold induction of 198 mROS was detected in mitochondria from 4-hour M1 stimulated M-BKO, but not WT 199 macrophages. Hif-1a protein accumulation could be normalized between genotypes by co-200 treatment with the antioxidant N-acetylcysteine (N-AC) or the competitive complex II inhibitor 201 dimethylmalonate (DMM) that blocks mROS production ( Figure 4D ). Furthermore, M1-202 stimulated glucose uptake, lactate release and aerobic glycolysis were attenuated in myeloid-203 specific Bmal1 and Hif1a double knockout macrophages (M-BHdKO, Figure 4 supplemental 204 figure 1B-D), indicating the increased glucose utilization in M-BKO was Hif-1a-dependent. 205
A previous study suggests that Bmal1 deletion impairs the expression of Nfe2l2 (which 206 encodes Nrf2) and its downstream antioxidant genes thereby increasing oxidative stress (Early et 207 al., 2018) . However, we found that expression Nfe2l2 and Nrf2-induced oxidative stress responsive 208 genes, such as NAD(P)H quinone dehydrogenase 1 (Nqo1, Figure 4 supplemental figure 1E ), were 209 up-regulated in M-BKO macrophages upon M1 stimulation, suggesting that increased mROS 210 associated with M-BKO was the cause rather than consequence of dysregulated Nrf2 signaling. 211
Collectively, these data indicate that Bmal1 and Hif-1a regulate opposing metabolic programs and 212 that Bmal1-mediated mitochondrial metabolism serves to fine-tune Hif-1a activity by modulating 213 oxidative stress. 214 215
Bmal1 loss-of-function induces metabolic reprogramming toward amino acid catabolism 216
To fully characterize metabolic programs that were impacted by Bmal1 loss-of-function, 217
we compared RNA-seq data from control and M1-activated WT and M-BKO macrophages. These 218 analyses revealed that the majority of M1-induced or suppressed genes were regulated in a similar 219 manner between WT and M-BKO macrophages, suggesting that Bmal1 gene deletion did not cause 220 a general defect in inflammatory activation (Figure 5 supplemental figure 1A and Figure 5  221  supplemental table 1). Gene ontology analyses of the top enriched categories of M1-upregulated  222   genes shared by both genotypes included regulation of apoptosis, response to stress and cytokine  223 production. Among the top categories of suppressed genes were the cell cycle, DNA repair and 224 carbohydrate metabolism. The latter showed that most TCA cycle enzymes were down-regulated 225 by M1 activation ( Figure 5A ). 226
Direct comparison between M1-stimulated WT and M-BKO macrophages revealed that 227 genes more highly expressed in M1-activated M-BKO macrophages were enriched for protein 228 catabolism and amino acid transport ( Figure 5 supplemental figure 1B and Figure 5 supplemental 229 table 1). These included genes encoding plasma membrane amino acid transporters (e.g., Slc7a2, 230
Slc7a8, Slc7a11, Slc38a2 and Slc38a7) as well as ubiquitin-activating, -conjugating and -ligating 231 enzymes that target proteins for proteasomal degradation (e.g., ubiquitin-like modifier-activating 232 enzyme 6 (Uba6), ubiquitin conjugating enzymes Ube2q2 and Ube2e3, ring finger proteins Rnf12, 233
Rnf56, Rnf128, and Rnf171, cullin 3 (Cul3) and Cul5, and ubiquitin protein ligase e3a (Ube3a)) 234 ( Figure 5A Slc7a8, also called L-type amino acid transporter 2 (Lat2), transports neutral amino acids 242 that could be converted to succinate and potentially contribute to Hif-1a protein stabilization. In 243 line with increased amino acid metabolism, extracellular flux analysis showed that M-BKO 244 macrophages showed enhanced glutamine utilization compared to WT cells, which was blocked 245 by 2-amino-bicyclo-(2,2,1)-heptane-2-carboxylate (BCH), an L-type amino acid transporter 246 inhibitor (Christensen, Handlogten Figure 5C ). In addition, treatment with either BCH or DMM 249 suppressed the expression of Il1b, Slc7a8 and Slc7a11 induced by M1 stimulation ( Figure 5D ). 250
The combination of BCH and DMM did not exert a greater effect over that of DMM alone. Thus, 251 amino acid metabolism is up-regulated in response to dysregulated energy metabolism in M-BKO 252 macrophages, which contributes to increased oxidative stress and Hif-1a activation. conditions. We sought to determine whether the Bmal1-Hif-1a crosstalk plays a role in modulating 262 TAM activation through a mechanism similar to that in M1 stimulation. Treatment of macrophages 263 with conditioned medium from primary B16-F10 tumors (T-CM) increased the expression of 264
Bmal1 mRNA as well as protein ( Figure 6A ). M-BKO macrophages showed enhanced mROS 265 production and Hif-1a protein induced by T-CM, compared to WT macrophages ( Figure 6B -C). 266
Tracking with Hif-1a stabilization, aerobic glycolysis was up-regulated by T-CM pretreatment in 267 gene expression signature resembling M1 stimulation, including up-regulated amino acid 269 metabolism (Arg1, Slc7a8 and Bckdhb) and oxidative stress (Slc7a11 and Nqo1) pathways in WT 270 macrophages that were further induced by M-BKO ( Figure 6E ). Subsequently, we employed a 271 mouse model of melanoma through subcutaneous injection of B16-F10 melanoma cells to assess 272 the impact of myeloid Bmal1 deletion on tumor growth. Tumor volume was increased in both male 273 and female M-BKO mice compared to WT controls ( Figure 6F ). Furthermore, the expression of 274 Arg1, Slc7a8 and Slc7a11 was up-regulated in F4/80 + cells isolated from tumors but not spleens 275 of M-BKO mice compared to WT animals ( Figure 6G ). Of note, the mRNA levels of Arg1, Slc7a8 276 and Slc7a11 were substantially higher in tumor versus splenic F4/80 + cells, consistent with the 277 results observed in T-CM treated macrophages. 278
To confirm that macrophage Bmal1 modulates tumor growth cell-autonomously and assess 279 the effect of TAMs on anti-tumor immune response within the same host environment, we co-280 injected B16-F10 cells with either WT or M-BKO macrophages into the right or left flanks, 281 respectively, of WT mice. Tumor growth rate was substantially higher when co-injected with M-282 BKO macrophages compared to WT cell co-injection ( Figure 7A ). In concert, co-injection with 283 M-BKO macrophages led to a reduction in the CD8 + T cell population among tumor-infiltrating 284 CD45 + leukocytes as well as functionally primed CD8 + T and NK cells that expressed Ifn-g protein 285 following stimulation with phorbol myristate acetate and ionomycin ex vivo ( Figure 7B figure 1E ). The crosstalk between these 338 two bHLH transcription factors is in part mediated by succinate and SDH/complex II-facilitated 339 mROS production. Succinate is one of the entry points for anerplerosis that attempts to replenish 340 TCA cycle metabolites depleted by disruption of mitochondrial oxidative metabolism. Increased 341 protein/amino acid catabolism provides a source of anerplerotic reactions. Succinate accumulation 342 and the subsequent oxidation to fumarate, however, generate mROS, which stabilizes Hif-1a 343 protein to drive aerobic glycolysis. Our data suggest that amino acid metabolism appears to be 344 down-and up-regulated by Bmal1 and Hif-1a, respectively, as demonstrated by the regulation of 345 Arg1 and Slc7a8 gene expression. Hif-1a has also been shown to regulate Bnip3-mediated 346 mitophagy that reduces mitochondrial oxidative capacity (Zhang et al., 2008) . Therefore, Bmal1-347 controlled mitochondrial metabolism provides a break to this feedforward cycle to limit 348 inflammatory damage. In line with this, previous work has demonstrated that myeloid Bmal1 349 knockout mice have reduced survival rate upon L. monocytogenes infection (Nguyen et al., 2013) . with LPS (or LPS shock), BMDMs or MEFs were given fresh culture medium with 2% FBS and 423 100 ng/mL LPS for 1 hour and then given fresh medium with 2% FBS without LPS. Bmal1 424 expression was tracked following LPS removal. For M1 or LPS induction of Bmal1 expression, 425 cells were primed with or without 10 ng/mL Ifn-g for 10-12 hours in DMEM, 10% FBS and 426 subsequently stimulated with 10 ng/mL of LPS without changing the medium (time zero). 427 428 Cell lines. Mouse embryonic fibroblasts (MEFs) were isolated from WT C57/BL6J mouse 429 embryos and immortalized using the 3T3 protocol as previously described (Xu, 2005) 10-12 weeks were subcutaneously injected in the right flank with 300,000 B16-F10 mouse 443 melanoma cells. For co-injection experiments, 500,000 B16-F10 cells were mixed with either 444 500,000 WT or M-BKO BMDMs (differentiation for 6 day) in the right and left flanks, 445 respectively. Tumor dimensions were measured every two days by caliper after all mice had 446 palpable tumors, and tumor volume was calculated as LxWxWx0.52 as previously 447 described (Colegio et al., 2014) . For DMM treatment, mice were switched to soft pellet, high fat 448 diet (Bio-Serv, F3282) so that DMM can be mixed with the diet using a blender. The tumor growth 449 rate was slower on high fat diet ( Figure 7C Readings were normalized to total cellular protein content. 504 505 Mitochondrial isolation. Mitochondria were isolated from primary BMDMs by differential 506 centrifugation. In brief, cells were resuspended in 500 µL of ice-cold mitochondrial isolation 507 buffer consisting of 70 mM sucrose, 50 mM Tris, 50 mM KCl, 10 mM EDTA, and 0.2% fatty-acid 508 free BSA (pH 7.2) and then extruded through 29-gauge syringes 20 times. Lysates were spun at 509 800g to pellet nuclei, and supernatants were spun at 8,000g to isolate mitochondria. Pelleted 510 mitochondria were washed once more with 500 µL of mitochondria isolation buffer. Total 511 mitochondrial protein content was determined by BCA assay. 512 513 ETC activity assays in isolated mitochondria. The activities of ETC complexes I-IV were 514 measured in isolated mitochondria using colorimetric assays as previously described ( homogenized by metal bead beating, and metabolites were extracted using 80% methanol. 555
Following extraction, cell pellets were solubilized using Tris-HCl Urea buffer (pH 8.0) containing 556 1% SDS to measure cellular protein content for each sample. All metabolite readings were 557 normalized to total protein content. 558 559 Collection of tumor-conditioned medium. Mice bearing subcutaneous B16-F10 tumors were 560 sacrificed 20 days after injection with 500,000 cells. Tumors were dissected and weighed. Tumors 561 were minced in growth medium containing 10% dialyzed FBS in high glucose DMEM (5 mL per 562 gram of tissue) and incubated at 37°C for 2 hours. Conditioned medium was collected and filtered 563 through 100 µm strainer followed by three spins at 1,000 rpm to pellet and remove residual 564 cells/debris from the medium. 565 566
Isolation of tumor-infiltrating immune cells. Subcutaneous mouse tumors were dissected, 567
weighed, and then placed in 6-well plates with growth medium (RPMI, 5% FBS) and minced. 568
Minced tissues were combined into three groups per genotype, spun down in 50 mL conical tubes, 569 and resuspended in 20 mL digestion buffer (0.5 mg/mL collagenase IV, 0.1 mg/mL DNase I in 570 HBSS medium). Tumors were digested at 37°C with gentle shaking for 30 minutes and vortexed 571 every 10 minutes. Contents were filtered through a 100 mm mesh, and cells were pelleted and 572 resuspended in 45% percoll in 1X HBSS and 1X PBS. Cells were spun at 2,000 rpm at 4°C with 573 a swing bucket rotor for 20 minutes. The supernatant was aspirated, and the pellet was briefly 574 resuspended in 5 mL ACK buffer to lyse red blood cells. Lastly, cells were pelleted and 575 resuspended in growth medium for downstream applications. 576
To isolate F4/80 + cells from tumors, tissues were homogenized and processed as above to 577 collect tumor-infiltrating leukocytes. F4/80 + cells were then isolated by positive selection using a 578 Genes encoding transcriptional regulators that were significantly induced or repressed by 8h M1 stimulation (p<0.05, FDR<0.05, |F.C.|>1.5) in WT bone marrow derived macrophages were identified by gene ontology analysis using the DAVID platform. Differentially regulated genes that matched the Transcription GO term in the Biological Processes GO database (accession GO:0006350) were used to generate a protein-protein interaction map using String (Supplemental figure 1) . Uncharacterized zinc finger proteins (ZFPs) were omitted from analyses by String. Genes are listed below: HBP1  KEAP1  MYB  PTRF  SPEN  ZSCAN29  AKNA  DAXX  HDAC1  KLF11  NAB2  PURA  SPIC  ZXDB  ANP32A  DDIT3  HES1  KLF16  NACC1  RBPJ  SREBF1  ARHGAP22 DDX54  HES7  KLF4  NCOA5  RCOR2  SRF  ARID3A  DEDD2  HEXIM1  KLF7  NCOA7  REL  ST18  ARID5A  DNMT3A HIC1  KLF9  NCOR2  RELA  STAT2  ARNT2  DPF1  HIC2  LCOR  NFAT5  RELB  STAT3  ASF1A  DRAP1  HIF1A  LCORL NFE2L2  REST  STAT4  ATF3  E2F5  HIF3A  LHX2  NFIL3  RFX1  STAT5A  ATF4  E4F1  HINFP  LIN54  NFKB1  RING1  TAF1C  ATF6B  EAF1  HIVEP1  LITAF  NFKB2  RNF2  TAF7  ATXN7L3  EDF1  HIVEP2  LMO4  NFKBIZ RORA  TAL1  BANP  EGR2  HIVEP3  MAF  NOTCH1 RREB1  TBL1X  BATF  EID3  HLX  MAFF  NPTXR  RSLCAN18 TCEB2  BCL3  EIF2C1  HMG20B  MAFG  NR1D1  RUNX2  TCF4  BCL6  ELK1  HMGA1  MAFK  NR1D2  RUNX3  TGIF1  BCORL1  ELL  HMGA1-RS1 MAML1 NR1H2  RUVBL2  THAP7  BHLHE40  ELL2  HMGN5  MAX  NR1H3  RXRA  TLE2  BHLHE41  ELL3  HOPX  MBD2  NR2F6  RYBP  TLE3  BRWD1  EPAS1  HSF4  MDFIC  NR4A1  SAFB2  TRERF1  BTG2  ERF  IFI205  MECP2 NR4A2  SAP130  TRIB3  CAMTA2  ERN1  IFT57  MED13 NR4A3  SAP30  TRRAP  CASZ1  ESRRA  ILF3  MED13L PAF1  SBNO2  TSC22D4  CBX4  ETS1  ING2  MED15 PAX4  SCAF1  TSHZ1  CCDC85B  ETV3  IRF2BP1  MED25 PCGF3  SEC14L2  USP49  CDKN2A  FIZ1  IRF4  MED26 PCGF5  SERTAD1  VPS72  CEBPB  FLII  IRF7  MED28 PER1  SETD8  WHSC1L1  CEBPD  FOXP1  IRF8  MED31 PER2  SFPI1  ZBTB17  CITED4  FOXP4  JARID2  MEF2D PHF1  SIN3B  ZBTB24  CREB5  GATA2  JDP2  MIER2  PHF12  SIX1  ZBTB46  CREBBP  GATAD2A JMJD6  MIER3  PIAS4  SIX5  ZBTB7A  CREBL2  GATAD2B JUN  MITF  PML  SLC30A9  ZBTB7B  CREBZF  GFI1  JUNB  MIXL1  POU2F2  SMAD3  ZEB1  CREM  GLIS3  JUND  MKL1  POU3F1  SMAD4  ZFHX4  CRTC2  GPBP1  KDM3A  MLL1  POU6F1  SMAD7  ZGPAT  CRTC3  GRHL1  KDM4A  MNDA  PPARD  SMYD1  ZHX2 Repressed (195 genes)  ACTL6A  ELK3  IRF2  NAA15  SAP18  AHRR  ELP2  ITGB3BP NCOA1  SAP25  AI987944  ELP3  KDM2B  NCOA3  SETD7  ANG  ELP4  KLF10  NFATC1  SETDB1  ASCC1  ENY2  KLF13  NFATC2  SNAPC5  ASF1B  ERCC8  KLF2  NFIA  SP3  ATAD2  ESR1  KLF8  NKRF  SSBP2  AW146154 ETOHI1  L3MBTL2 NPAT  SSRP1  BCL9L  ETV1  LBH  NPM3  STAT1  CBFA2T3 EYA1  LRPPRC NR2C1  SUV39H1  CBX3  EYA4  LYL1  NRIP1  SUV39H2  CBX6  EZH2  MAFB  OVOL2  SUV420H2  CBX8  FLI1  MARS  PA2G4  TADA1  CCNH  FNTB  MBTPS2 PHF19  TADA2A  CDCA7  FOXM1  MCM2  PHTF2  TAF4B  CDCA7L  GTF2H2  MCM3  PNRC2  TAF9B  CEBPA  GTF2I  MCM4  POLR1B  TBX6  CEBPG  GTF2IRD1 MCM5  POLR2G  TCEA3  CEBPZ  GTF3A  MCM6  POLR2I  TCEAL8  CHAF1A  GTF3C5  MCM7  POLR3B  TCF7L2  CHAF1B  HABP4  MCM8  POLR3H  TFB1M  CHD9  HDAC10  MCTS1  POLR3K  TFB2M  CHURC1  HDAC11  MED14  PPARG  TFDP2  CIITA  HDAC2  MED18  PPARGC1B THOC1  CIR1  HDAC6  MED22  PRIM1  TLE1  CREB3  HDAC7  MED27  PRIM2  TRAPPC2  CREB3L1 HDAC8  MEF2A  PRMT7  TRIM24  CREB3L2 HDAC9  MEF2C  PROX2  TWISTNB  CTNND1  HELLS  MEIS1  PSPC1  TXNIP  CUX1  HHEX  MLF1IP  RAD54B  UHRF1  DDI2  HIP1  MLL3  RB1  USF1  DNMT1  HIRA  MLLT3  RBAK  VGLL4  DR1  HMBOX1  MNAT1  RCBTB1  VPS36  E2F1  HMGA2  MPV17  RCOR3  WTIP  E2F2  HOXA1  MXD3  RERE  ZBTB3  E2F6  HTATSF1  MXD4  RFC1  ZBTB8A  E2F7  IKBKAP  MYBL2  RPAP1  ZHX1  E2F8  IKZF2  MYC  RSC1A1  ZIK1  EGR3 IL16 MYCBP2 RSL1 ZKSCAN4 
